According to GlobalData’s medical device pipeline database, 13 Radiosurgery Systems devices are in various stages of development globally. GlobalData’s report Radiosurgery Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, five are in active development, while the remaining nine are in an inactive stage of development. There are two products in the early stages of development, and the remaining three are in the late stages of development.
General Surgery Devices market covers wide-ranging devices used in diagnostic and surgical procedures primarily for the gastrointestinal tract, abdomen, and pelvis. Radiosurgery systems are a type of radiation therapy that uses high-energy beams to precisely target tumors and other abnormalities in the body. There are two main types of radiosurgery systems:Gamma Knife systems use cobalt-60 radiation to deliver a single, high-dose of radiation to the target and Linear accelerator (LINAC)-based radiosurgery systems use high-energy X-rays to deliver multiple, smaller doses of radiation to the target.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Radiosurgery Systems pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Radiosurgery Systems devices. Overall, most of these Radiosurgery Systems pipeline devices are being developed by private entities.
Key players involved in the active development of Radiosurgery Systems include Accuray, Monteris Medical, StereoTools, University of California San Francisco, University of Hong Kong, Zap Surgical Systems, DiversiLabs, Elekta and Integra LifeSciences.
For a complete picture of the developmental pipeline for Radiosurgery Systems devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.